Black Diamond Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $224k | 90k | 2.48 |
| 2024-12-31 | $467k | 218k | 2.14 |
| 2024-09-30 | $544k | 125k | 4.35 |
| 2024-06-30 | $1.0M | 216k | 4.66 |
| 2024-03-31 | $299k | 59k | 5.07 |
| 2023-12-31 | $33k | 12k | 2.81 |
| 2023-09-30 | $63k | 22k | 2.87 |
| 2023-06-30 | $82k | 16k | 5.05 |
| 2022-12-31 | $62k | 31k | 2.00 |
| 2022-06-30 | $1.6M | 536k | 2.99 |
| 2022-03-31 | $1.4M | 493k | 2.81 |
| 2021-06-30 | $0 | 601k | 0.00 |
| 2020-12-31 | $3.6M | 112k | 32.04 |
| 2020-09-30 | $256k | 8.5k | 30.06 |
| 2020-06-30 | $161k | 3.8k | 42.19 |
| 2020-03-31 | $35k | 1.4k | 25.00 |